<DOC>
	<DOC>NCT02969174</DOC>
	<brief_summary>To establish a genotyping and extraction technology of non invasive prenatal diagnosis for fetal blood group genotype from cell-free fetal DNA in peripheral blood of pregnant women. To achieve prenatal accurate identification of fetal blood group genotypesï¼Œand provide credible theoretical evidence for the prenatal diagnosis and treatment of hemolytic disease of newborn (HDN).</brief_summary>
	<brief_title>Establish a Non-invasive Prenatal Genotyping and Extraction Technology to Diagnose and Treat the HDN.</brief_title>
	<detailed_description>Establish a Non-invasive Prenatal Genotyping and Extraction Technology to Diagnose and Treat the HDN.</detailed_description>
	<criteria>blood samples of pregnant couples,gender/nation/region is unlimited. adipose or hemolytic samples,overdue samples,unidentified samples</criteria>
	<gender>All</gender>
	<minimum_age>12 Weeks</minimum_age>
	<maximum_age>38 Weeks</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>